Alzheimer’s Disease: A Journey from Amyloid Peptides and Oxidative Stress, to Biomarker Technologies and Disease Prevention Strategies—Gains from AIBL and DIAN Cohort Studies
Ralph N. Martins(Edith Cowan University), Colin L. Masters(Mental Health Research Institute)
Cited by 130
Related Papers
Biochemistry of Amyloid -Protein and Amyloid Deposits in Alzheimer Disease
|Cold Spring Harbor Perspectives in Medicine|2012|534
Degradation of the Alzheimer Disease Amyloid β-Peptide by Metal-dependent Up-regulation of Metalloprotease Activity
|Journal of Biological Chemistry|2006|283
Stabilization of Nontoxic Aβ-Oligomers: Insights into the Mechanism of Action of Hydroxyquinolines in Alzheimer's Disease
|Journal of Neuroscience|2015|72